Concepedia

Andreas Spitzmueller

AS

Statistics

Publications

3

Citations

406

H-Index

3

Active since

2017

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

Andreas Spitzmueller is an author at AstraZeneca (United States) specializing in medicine, oncology, and immunotherapy.

Publications per year

2017–2021

3

Publications

3

Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen

Michael P. Menden, Dennis Wang, Mike J. Mason et al. · Nature Communications · 2019 · 363 citations · Full text

, , +16

Abstract PD6-01: Novel approach to HER2 quantification: Digital pathology coupled with AI-based image and data analysis delivers objective and quantitative HER2 expression analysis for enrichment of responders to trastuzumab deruxtecan (T-DXd; DS-8201), specifically in HER2-low patients

Mark Gustavson, Susanne Haneder, Andreas Spitzmueller et al. · Cancer Research · 2021 · 30 citations

, , +17

Mutually exclusive expression of CD73 and PDL1 in tumors from patients (pt) with NSCLC, gastroesophageal (GE) and urothelial bladder carcinoma (UBC).

Philip Martin, Andreas Spitzmueller, Song Wu et al. · Journal of Clinical Oncology · 2017 · 13 citations

, , +17

1–3 of 3